Therapeutic modulation of CXCL1 dysregulation in fibroblasts represents a promising strategy not only for periodontitis management but also for ameliorating diabetes-related complications, including insulin resistance and impaired wound healing (Shinjo et al., 2023). This evidence concerns the gene CXCL1 and diabetes mellitus.